AAMRI is a co-signatory to a joint letter to the Review of the Research & Development Tax Incentive. Other co-signatories are: AusBiotech, Research Australia, Medicines Australia,...

As part of the National Innovation and Science Agenda (NISA), the Federal Government will provide a non-refundable tax offset and a capital gains tax exemption for early stage investments in...

AAMRI has made its 2016-17 pre-Budget submission. Central to our submission are: The urging of the Government to stand firm on its commitment to build the Medical Research Future Fund (MRFF) to...

AAMRI welcomes the opportunity to provide feedback on the draft revised Australian Code for the Responsible Conduct of Research. Overall, the draft revised Code is a tremendous improvement on the ...

AAMRI commends the Government on tackling the complex but critical issue of research policy and funding arrangements affecting the outcomes and impact of Australian research. This review could...

AAMRI Victoria’s response to the Victorian Government’s discussion paper focuses on seven key areas and initiatives that are required to transform the medical technology and...

AAMRI makes this submission on behalf of our 46 member institutes, which supervise and train over 1,500 Higher Degree Research (HDR) students each year. Through their close links with health...

AAMRI Victoria welcomes the initiative of the Victorian Government in developing a Victorian Health and Medical Research Strategy. In doing so, we note that it is critical that the State’s...

The MRFF Action Group welcomes the opportunity to make this submission. By focusing on the nexus between research and innovation, the Medical Research Future Fund provides an extraordinary...